Guohua Yu

机构：Qingdao University, Weifang Medical University, Binzhou Medical University, Shandong University of Aeronautics, Northwestern Polytechnical University, Beijing University of Chinese Medicine, Longyan University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Yuhuangding Hospital, Weifang People's Hospital, Guang’anmen Hospital, Ministry of Agriculture and Rural Affairs, National Engineering Research Center for Information Technology in Agriculture, China Agricultural University, Southern Medical University · ORCID：0000-0002-3260-3178

发表论文 147 篇 · 总被引 1863 次 · h-index 23

代表论文

• Results of a phase 1/2 study of sacituzumab tirumotecan in patients with unresectable locally advanced or metastatic solid tumors refractory to standard therapies (2025 · Journal of Hematology & Oncology · 被引 23)
• Multimodal fusion model for prognostic prediction and radiotherapy response assessment in head and neck squamous cell carcinoma (2025 · npj Digital Medicine · 被引 18)
• Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study. (2025 · Journal of Clinical Oncology · 被引 12)
• Spatial multi-omics profiling of breast cancer oligo-recurrent lung metastasis (2025 · Oncogene · 被引 11)
• Multi-objective optimal design for flexible bio-inspired meta-structure with ultra-broadband microwave absorption and thin thickness (2025 · Chinese Journal of Aeronautics · 被引 11)
• Camrelizumab Plus Famitinib versus Camrelizumab Alone and Investigator's Choice of Chemotherapy in Recurrent or Metastatic Cervical Cancer: A Randomized, Phase II Study (2025 · Journal of Clinical Oncology · 被引 8)